Cargando…

Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas

BACKGROUND: The phase 2 REGOMA trial suggested an encouraging overall survival benefit in glioblastoma patients at first relapse treated with the multikinase inhibitor regorafenib. Here, we evaluated the efficacy and side effects of regorafenib in a real-life setting. METHODS: From 2018 to 2021, 30...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werner, Jan-Michael, Wolf, Lena, Tscherpel, Caroline, Bauer, Elena K., Wollring, Michael, Ceccon, Garry, Deckert, Martina, Brunn, Anna, Pappesch, Roberto, Goldbrunner, Roland, Fink, Gereon R., Galldiks, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424167/ https://www.ncbi.nlm.nih.gov/pubmed/35716310 http://dx.doi.org/10.1007/s11060-022-04066-9

Ejemplares similares

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine
por: Ceccon, Garry, et al.
Publicado: (2020)

Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
por: Ceccon, Garry, et al.
Publicado: (2018)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[(18)F]-fluoroethyl)-l-tyrosine PET
por: Bauer, Elena K., et al.
Publicado: (2020)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

Advances in PET imaging for meningioma patients
por: Galldiks, Norbert, et al.
Publicado: (2023)

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
por: Lohmann, Philipp, et al.
Publicado: (2019)

Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment
por: Kocher, Martin, et al.
Publicado: (2020)

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis
por: Heinzel, Alexander, et al.
Publicado: (2023)

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
por: Lohmann, Philipp, et al.
Publicado: (2018)

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
por: Bauer, Elena Katharina, et al.
Publicado: (2021)

Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
por: Kocher, Martin, et al.
Publicado: (2021)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2009)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
por: Werner, Jan-Michael, et al.
Publicado: (2020)

Extracranial Metastases of a Cerebral Glioblastoma: A Case Report and Review of the Literature
por: Rosen, Jurij, et al.
Publicado: (2018)

Erratum to: Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2010)

Use of advanced neuroimaging and artificial intelligence in meningiomas
por: Galldiks, Norbert, et al.
Publicado: (2022)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
por: Treiber, Hannes, et al.
Publicado: (2022)

Brain responsivity provides an individual readout for motor recovery after stroke
por: Tscherpel, Caroline, et al.
Publicado: (2020)

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients
por: Zeiner, Pia S., et al.
Publicado: (2019)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Two Decades of Brain Tumour Imaging with O-(2-[(18)F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
por: Heinzel, Alexander, et al.
Publicado: (2022)

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management
por: Del Prete, Michela, et al.
Publicado: (2015)

Feature-based PET/MRI radiomics in patients with brain tumors
por: Lohmann, Philipp, et al.
Publicado: (2021)

Case report: Use of (68)Ga-DOTATATE-PET for treatment guidance in complex meningioma disease
por: Meißner, Anna-Katharina, et al.
Publicado: (2022)

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
por: Werner, Jan-Michael, et al.
Publicado: (2019)

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
por: Galldiks, Norbert, et al.
Publicado: (2020)

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study
por: Marrari, Andrea, et al.
Publicado: (2020)

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
por: Friedrich, Michel, et al.
Publicado: (2022)

Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
por: Perng, Powell, et al.
Publicado: (2015)

Age affects the contribution of ipsilateral brain regions to movement kinematics
por: Tscherpel, Caroline, et al.
Publicado: (2019)

Intermittent theta burst stimulation applied during early rehabilitation after stroke: study protocol for a randomised controlled trial
por: Hensel, Lukas, et al.
Publicado: (2019)

TERT and its binding protein: overexpression of GABPA/B in high grade gliomas
por: Papazacharias, Efthymios, et al.
Publicado: (2021)

Early motor network connectivity after stroke: An interplay of general reorganization and state‐specific compensation
por: Paul, Theresa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5dt233j1hlr4s0ubj97395sr0